| 765518 |
FRONTIERS IN ONCOLOGY |
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer |
2021-11-03 |
10.3389/fonc.2021.783327 |
Kim Tae Hyun, Lee Keun Seok, Sim Sung Hoon, Kim Yeon-Joo, Kim Dae Yong, Chae Heejung, Lee Eun-Gyeong, Han Jai Hong, Jung So Youn, Lee Seeyoun, Kang Han Sung, Lee Eun Sook |
| 765517 |
FRONTIERS IN ONCOLOGY |
Intertumoural Heterogeneity and Branch Evolution of Synchronous Multiple Primary Lung Adenocarcinomas by Next-Generation Sequencing Analysis |
2021-11-03 |
10.3389/fonc.2021.760715 |
Zhang Qinleng, Jia Hui, Wang Zhendan, Hao Shaoyu, Huang Haiyan, Yang Airong, Han Lu, Song Pingping |
| 765516 |
FRONTIERS IN ONCOLOGY |
Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma |
2021-11-03 |
10.3389/fonc.2021.758503 |
Kamada Shuhei, Ikeda Kazuhiro, Suzuki Takashi, Sato Wataru, Kitayama Sachi, Kawakami Satoru, Ichikawa Tomohiko, Horie Kuniko, Inoue Satoshi |
| 765515 |
FRONTIERS IN ONCOLOGY |
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer |
2021-11-03 |
10.3389/fonc.2021.777867 |
Portman Neil, Chen Julia, Lim Elgene |
| 765514 |
FRONTIERS IN ONCOLOGY |
Assessment and Prognostic Value of Immediate Changes in Post-Ablation Intratumor Density Heterogeneity of Pulmonary Tumors via Radiomics-Based Computed Tomography Features |
2021-11-03 |
10.3389/fonc.2021.615174 |
Liu Bo, Li Chunhai, Sun Xiaorong, Zhou Wei, Sun Jing, Liu Hong, Li Shuying, Jia Haipeng, Xing Ligang, Dong Xinzhe |
| 765513 |
FRONTIERS IN ONCOLOGY |
Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer |
2021-11-03 |
10.3389/fonc.2021.738801 |
Bai Liping, Pfeifer Tobias, Gross Wolfgang, De La Torre Carolina, Zhao Shuyang, Liu Li, Schaefer Michael, Herr Ingrid |
| 765512 |
FRONTIERS IN ONCOLOGY |
Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin |
2021-11-03 |
10.3389/fonc.2021.771454 |
Gerousi Marina, Laidou Stamatia, Gemenetzi Katerina, Stamatopoulos Kostas, Chatzidimitriou Anastasia |
| 765511 |
FRONTIERS IN ONCOLOGY |
Intertumoral Heterogeneity of Primary Breast Tumors and Synchronous Axillary Lymph Node Metastases Reflected in IHC-Assessed Expression of Routine and Nonstandard Biomarkers |
2021-11-03 |
10.3389/fonc.2021.660318 |
Kuncman Wojciech, Orzechowska Magdalena, Kuncman Łukasz, Kordek Radzisław, Taran Katarzyna |
| 765510 |
FRONTIERS IN ONCOLOGY |
miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer |
2021-11-03 |
10.3389/fonc.2021.740452 |
Mei Yu, Li Kai, Zhang Zhicheng, Li Mengmeng, Yang Hong, Wang Hui, Huang Xuemei, Li Xinyuan, Shi Shuhua, Yang Huanjie |
| 765509 |
FRONTIERS IN ONCOLOGY |
Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer |
2021-11-03 |
10.3389/fonc.2021.763035 |
Zhu Xiaoxi, Zhou Renyu, Lu Yuanzhi, Zhang Ying, Chen Qiang, Li Yin |
